Abbott is making its BinaxNOW COVID-19 test available to schools, pharmacies, universities and workplaces, CNBC reported Jan. 12. Since the test was authorized in August, Abbott has distributed 150 ...

Nov 16 (Reuters) - The U.S. government will send over 7 million of Abbott Laboratories' (ABT.N), opens new tab BinaxNOW rapid antigen tests for COVID-19 to states, hospice providers, and for other ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Dr. Soren Christiansen, former Head of Vaccines at Merck and CEO of Sharps Technology, joined The Final Round to discuss the latest developments regarding a COVID-19 vaccine and his thoughts on the ...

INDIANAPOLIS, (WISH) – The holidays are about spreading joy, but it’s also a time when celebrating with friends and family can get us sick. On Tuesday, Dr. Mary Rodgers, a Ph.D. who is an Abbott ...

NEW YORK CITY (WABC) -- It could be a game changer in COVID 19 testing: A company with offices in the Tri-State area received emergency authorization from the FDA for a test that could get results ...

CHICAGO (WLS) -- A new COVID19 test that provides results in five minutes is set to roll out soon as Illinois-based Abbott Labs expected to deliver 50,000 tests per-day. President Donald Trump did a ...

(Reuters) - The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could ...

Abbott Laboratories narrowed its full-year outlook as sales of COVID-19 tests slide. COVID-19 test sales in the second quarter dropped 46% from the year before. Second-quarter earnings and revenue ...

(Reuters) -Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, and the government's foreign ...

Medical devices continue to be a strong growth driver for Abbott, as the company battles its ongoing sales slump in diagnostics, which accelerated in the third quarter. Third-quarter revenue for its ...